Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Osprey Medical Inc (OSP.AX)

Osprey Medical Inc (OSP.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Osprey Medical Inc 5600 Rowland Road Suite 250 Minnetonka MN 55343 USA

https://www.ospreymed.com P: 952-955-8230 F: 952-955-8171

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Osprey Medical Inc is a United States-based, commercial stage, medical device company. It focuses on protecting patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures in the US. The company's technology includes DyeVert Plus EZ and DyeVert Plus, which reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures.

Key Statistics

Overview:

Market Capitalization, $K 5,132
Shares Outstanding, K 25,659
% of Institutional Shareholders 2.58%

Financials:

Annual Sales, $ 1,960 K
Annual Net Income, $ -10,046 K

Growth:

1-Year Return -89.47%
3-Year Return -98.46%
5-Year Return -99.53%
5-Year Revenue Growth 27.35%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.41
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 09/15/21

OSP.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -209.65%
Return-on-Assets % -134.42%
Profit Margin % -512.51%
Debt/Equity 0.02
Price/Sales 1.72
Price/Book 0.68
Book Value/Share 0.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar